Keywords
Dermatology ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

- 9/16/20 - 1 form, 9 itemgroups, 58 items, 1 language
Itemgroups: Administrative, Study Treatment Administration (Visit 1), Study Treatment Administration (Visit 2 - 6, 8 - 13, 15 - 18, 20 - 27) , Tumor Assessment (Visit 7, 11, 14, 19, 21, 23 - 28, Follow-up), Tumor Assessment (Visit 7, 11, 14, 19, 21, 23 - 28, Follow-up) , Site evaluation for non-target lesion(s) and new lesions (Visit 7, 11, 14, 19, 21, 23 - 28, Follow-up), Site evaluation for non-target lesion(s) and new lesions (Visit 7, 11, 14 ,19, 21, 23 - 28, Follow-up), Target lesion(s) evaluation (Visit 7, 11, 14, 19, 21, 23 - 28, Follow-up), Response Assessment (Visit 7, 11, 14, 19, 21, 23 - 28, Follow-up)
- 9/16/20 - 1 form, 14 itemgroups, 39 items, 1 language
Itemgroups: Administrative, Unscheduled Visit , Physical Examination (Unscheduled Visit), Weight (Unscheduled Visit) , Conclusion of unscheduled visit , Unscheduled Tumor Assessment, Tumor Assessment, Tumor Assessment , Site evaluation for non-target lesion(s) and new lesions, Site evaluation for non-target lesion(s) and new lesions, Target lesion(s) evaluation, Response Assessment, Laboratory Tests, Laboratory Tests
- 9/16/20 - 1 form, 14 itemgroups, 39 items, 1 language
Itemgroups: Administrative, Unscheduled Visit , Physical Examination (Unscheduled Visit), Weight (Unscheduled Visit) , Conclusion of unscheduled visit , Unscheduled Tumor Assessment, Tumor Assessment, Tumor Assessment , Site evaluation for non-target lesion(s) and new lesions, Site evaluation for non-target lesion(s) and new lesions, Target lesion(s) evaluation, Response Assessment, Laboratory Tests, Laboratory Tests
- 9/14/20 - 1 form, 43 itemgroups, 91 items, 1 language
Itemgroups: Administrative, Check for Study Continuation (Visit 1), Check for Study Continuation (Visit 2) , Check for Study Continuation (Visit 3) , Check for Study Continuation (Visit 4), Check for Study Continuation (Visit 5) , Check for Study Continuation (Visit 6) , Check for Study Continuation (Visit 7) , Check for Study Continuation (Visit 8) , Check for Study Continuation (Visit 9) , Check for Study Continuation (Visit 10) , Check for Study Continuation (Visit 11) , Check for Study Continuation (Visit 12) , Check for Study Continuation (Visit 13), Check for Study Continuation (Visit 14), Check for Study Continuation (Visit 15) , Check for Study Continuation (Visit 16) , Check for Study Continuation (Visit 17) , Check for Study Continuation (Visit 18) , Check for Study Continuation (Visit 19) , Check for Study Continuation (Visit 20) , Check for Study Continuation (Visit 21) , Check for Study Continuation (Visit 22), Check for Study Continuation (Visit 23) , Check for Study Continuation (Visit 24) , Check for Study Continuation (Visit 25), Check for Study Continuation (Visit 26), Check for Study Continuation (Visit 27), Check for Study Continuation (Visit 28) , Check for Study Continuation (Follow-Up) , Physical Examination (Visit 1), Physical Examination (Visit 2 - 6, 8 - 13, 15 - 18, 20 - 28), Physical Examination (Follow-Up) , Weight (Visit 1 - 6, 8 - 13, 15 - 18, 20 - 28, Follow-Up), Laboratory Tests (Visit 1, 3, 6, 8, 10, 14 - 18, 20 - 28), Haematology (Visit 1, 3, 6, 8, 10, 14 - 18, 20 - 28), Hepatic Function (Visit 1, 3, 6, 8, 10, 14 -18, 21, 23 - 28), Biochemistry (Visit 1, 3, 6, 8, 10, 14 - 18, 21, 23 - 28), Renal Function (Visit 1, 3, 6, 8, 10, 14 - 18, 21, 23 - 28), Humoral Immunity (Serum) (Visit 1, 3, 7, 14, 19, 21, 23 - 28, Follow-Up), Cellular Immunity (PBMC) (Visit 1, 7, 14, 19, 21, 23 - 26, 28, Follow-Up), HCG Urine or Blood Pregnancy Test (Visit 7, 11, 15, 17, 20 - 27), End of follow-up